Sitagliptin Medfour
Every registration of this product has been cancelled.
(3R)-3-Amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 4369359.
Registration
- Applicants
- 1
- Registrations
- 3
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Medfour Healthcare CCCancelled | Sitagliptin medfour | 25 mg, 50 mg, 100 mg | 550441, 550442, 550443 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Sitagliptin 25 MG medfour EACH TABLET CONTAINS SITAGLIPTIN HYDROCHLORIDE 25,0 mg | 25 mg | 55044155/21.2/0441 | Cancelled | Not determined | None |
| Sitagliptin 50 MG medfour EACH TABLET CONTAINS SITAGLIPTIN HYDROCHLORIDE 50,0 mg | 50 mg | 55044255/21.2/0442 | Cancelled | Not determined | None |
| Sitagliptin 100 MG medfour EACH TABLET CONTAINS SITAGLIPTIN HYDROCHLORIDE 100,0 mg | 100 mg | 55044355/21.2/0443 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.